AIMS: To assess the effect of a tailored multi-faceted improvement programme on general practitioners' (GPs') behaviour towards prevention of hazardous and harmful alcohol consumption. The improvement programme consisted of activities aimed at the GP, organization and patient. Educational training sessions and visits by a facilitator were tailored to the GPs' needs and attitudes. DESIGN: Cluster randomized controlled trial. SETTING: General practices in the Netherlands. PARTICIPANTS: Seventy-seven general practices; 119 GPs participated. Data from 6318 patients were available, of whom 765 (12.1%) were at risk. A total of 1502 patients' electronic medical records were reviewed. MEASUREMENTS: The primary outcome was the number of eligible patients who received screening and advice. FINDINGS: Difficulties in recruiting GPs and in motivating GPs for participation in the tailored parts of the programme impeded optimal implementation of the programme. Although GPs in both groups became more involved after enrolment, this improvement waned during the trial. The quality improvement programme enhanced the initial improvement in behaviour and it tempered waning (intervention group), compared to our control condition, resulting in average improvement rates of 5% (screening) and 2% (advice-giving) at 12-month follow-up (not significant). CONCLUSIONS: A tailored, multi-faceted programme aimed at improving general practitioner management of alcohol consumption in their patients failed to show an effect and proved difficult to implement. There remains little evidence to support the use of such an intensive implementation programme to improve the management of harmful and hazardous alcohol consumption in primary care.
RCT Entities:
AIMS: To assess the effect of a tailored multi-faceted improvement programme on general practitioners' (GPs') behaviour towards prevention of hazardous and harmful alcohol consumption. The improvement programme consisted of activities aimed at the GP, organization and patient. Educational training sessions and visits by a facilitator were tailored to the GPs' needs and attitudes. DESIGN: Cluster randomized controlled trial. SETTING: General practices in the Netherlands. PARTICIPANTS: Seventy-seven general practices; 119 GPs participated. Data from 6318 patients were available, of whom 765 (12.1%) were at risk. A total of 1502 patients' electronic medical records were reviewed. MEASUREMENTS: The primary outcome was the number of eligible patients who received screening and advice. FINDINGS: Difficulties in recruiting GPs and in motivating GPs for participation in the tailored parts of the programme impeded optimal implementation of the programme. Although GPs in both groups became more involved after enrolment, this improvement waned during the trial. The quality improvement programme enhanced the initial improvement in behaviour and it tempered waning (intervention group), compared to our control condition, resulting in average improvement rates of 5% (screening) and 2% (advice-giving) at 12-month follow-up (not significant). CONCLUSIONS: A tailored, multi-faceted programme aimed at improving general practitioner management of alcohol consumption in their patients failed to show an effect and proved difficult to implement. There remains little evidence to support the use of such an intensive implementation programme to improve the management of harmful and hazardous alcohol consumption in primary care.
Authors: Steven J Ondersma; Jessica R Beatty; Dace S Svikis; Ronald C Strickler; Golfo K Tzilos; Grace Chang; George W Divine; Andrew R Taylor; Robert J Sokol Journal: Alcohol Clin Exp Res Date: 2015-05-22 Impact factor: 3.455
Authors: Rae Jean Proeschold-Bell; Donna M Evon; Christina Makarushka; John B Wong; Santanu K Datta; Jia Yao; Ashwin A Patkar; Paolo Mannelli; Terra Hodge; Susanna Naggie; Julius M Wilder; Michael W Fried; Donna Niedzwiecki; Andrew J Muir Journal: Contemp Clin Trials Date: 2018-07-10 Impact factor: 2.226
Authors: Jennifer McNeely; Angéline Adam; John Rotrosen; Sarah E Wakeman; Timothy E Wilens; Joseph Kannry; Richard N Rosenthal; Aimee Wahle; Seth Pitts; Sarah Farkas; Carmen Rosa; Lauren Peccoralo; Eva Waite; Aida Vega; Jennifer Kent; Catherine K Craven; Tamar A Kaminski; Elizabeth Firmin; Benjamin Isenberg; Melanie Harris; Andre Kushniruk; Leah Hamilton Journal: JAMA Netw Open Date: 2021-05-03
Authors: Jan Klimas; Rolande Anderson; Margaret Bourke; Gerard Bury; Catherine Anne Field; Eileen Kaner; Rory Keane; Eamon Keenan; David Meagher; Brian Murphy; Clodagh Sm O'Gorman; Thomas P O'Toole; Jean Saunders; Bobby P Smyth; Colum Dunne; Walter Cullen Journal: JMIR Res Protoc Date: 2013-08-02
Authors: Myrna N Keurhorst; Peter Anderson; Fredrik Spak; Preben Bendtsen; Lidia Segura; Joan Colom; Jillian Reynolds; Colin Drummond; Paolo Deluca; Ben van Steenkiste; Artur Mierzecki; Karolina Kłoda; Paul Wallace; Dorothy Newbury-Birch; Eileen Kaner; Toni Gual; Miranda G H Laurant Journal: Implement Sci Date: 2013-01-24 Impact factor: 7.327